A coalition of 40 advocacy groups is urging Senate Majority Leader Chuck Schumer (D-New York) to adopt a strong set of provisions to lower insulin prices and “put an end to insulin profiteering” in an upcoming health package. The groups, led by watchdog Public Citizen and diabetes advocacy group T1International, sent a letter to Schumer on Monday saying that, while some progress has been made over…